Potential type 2 diabetes mellitus drug HMPA promotes short‐chain fatty acid production by improving carbon catabolite repression effect of gut microbiota
- 7 December 2020
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 178 (4) , 946-963
Abstract
Background and Purpose: Gut microbiota plays an important role in type 2 diabetes mellitus (T2DM) progression. From our previous work N‐(4‐Hydroxyphenethyl)‐3‐mercapto‐2‐methylpropanamide (HMPA) is a potential T2DM drug. We evaluated the effect of HMPA on gut microbiota and studied the molecular mechanism underlying HMPA's regulation of gut microbiota.Experimental Approach: The pseudo germ‐free (PGF) T2DM model and faecal microbiota transplantation method were used to study whether gut microbiota mediates the actions of HMPA. The composition of gut microbiota was detected by using 16S rRNA sequence. Short‐chain fatty acids (SCFAs) content was detected by gas chromatography. The HMPA probe was synthesised for finding and identifying the target protein of HMPA. The effect of HMPA on the utilisation of carbon sources in Bifidobacterium was evaluated.Key Results: HMPA has a slight effect on the PGF T2DM model. The gut microbiota changed by HMPA can also alleviate the symptoms of T2DM. HMPA can regulate gut microbiota structure, increase SCFAs production and reduce nitrate content in the intestinal tissues. The thickness of the mucus on colon tissues increases after HMPA treatment. The target protein of HMPA in gut microbiota is the nitrogen metabolism global transcriptional regulator (GlnR). HMPA promotes the utilisation of less preferred carbon source in the gut microbiota and increases the fermentation product of SCFAs.Conclusion and Implications: HMPA plays a hypoglycaemic role through the gut microbiota. HMPA improves the carbon catabolite repression effect of gut microbiota and increases SCFAs production by targeting GlnR. GlnR may be a target for gut microbiota regulation.Keywords
Funding Information
- National Natural Science Foundation of China (81703581, 81972629, 81871972, 81572838, 81872374)
- National Key Research and Development Program of China (2018YFA0507203)
- Tianjin Municipal Science and Technology Committee (18PTSYJC00060)
This publication has 53 references indexed in Scilit:
- Predictive functional profiling of microbial communities using 16S rRNA marker gene sequencesNature Biotechnology, 2013
- STAT1, NF-κB and ERKs play a role in the induction of lipocalin-2 expression in adipocytesMolecular Metabolism, 2013
- Gut metagenome in European women with normal, impaired and diabetic glucose controlNature, 2013
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesityProceedings of the National Academy of Sciences, 2013
- Depletion of Murine Intestinal Microbiota: Effects on Gut Mucosa and Epithelial Gene ExpressionPLOS ONE, 2011
- Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic AdultsPLOS ONE, 2010
- Monitoring Bacterial Community of Human Gut Microbiota Reveals an Increase in Lactobacillus in Obese Patients and Methanogens in Anorexic PatientsPLOS ONE, 2009
- Human gut microbes associated with obesityNature, 2006
- Mechanisms linking obesity to insulin resistance and type 2 diabetesNature, 2006
- Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetesNature, 2005